Prasterone (GL701)

DRUG2 trials

Sponsors

Genelabs Technologies

Conditions

LupusSystemic Lupus Erythematosus

Phase 3

To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

Genelabs TechnologiesLupus

Start: 2002-12-31End: 2004-08-31Target: 155Updated: 2008-01-07

GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids

CompletedNCT00082511

Genelabs TechnologiesSystemic Lupus Erythematosus

Start: 2003-07-31End: 2005-08-31Updated: 2008-01-14